Research Article

Perioperative Antiviral Treatment Facilitate the Postoperative Recovery for Patients with HBV Related to Hepatocellular Carcinoma

Table 1

Comparison of clinical indexes among three patient groups

Index Pre-group(n=51) Post-group(n=52) Non-group(n=12) t1 Value P1 Value t2 Value P2 Value t3 Value P3 Value

Age (years) 50.85±10.63 49.36±11.46 44.92±13.88 0.616   0.539 1.585 0.119 -1.129 0.264
Sex (Female/Male) 8/43 6/46 4/8     0.539   0.161   0.061
Preoperative HBV DNA (log) 4.55±1.08 4.51±1.16 4.97±1.09 -0.139   0.890 1.23 0.224 1.23 0.224
Diameter of tumor (cm) 6.32±4.083 6.65±4.45 6.10±3.21 -0.314   0.754 -1.57 0.876 -.359 0.721
INR 1.02±0.07 1.03±0.09 1.04±0.12 -0.926   0.357 -0.314 0.628 0.175 0.862
Total bilirubin (umol/L) 13.52±4.68 13.64±5.24 11.91±5.58 -0.111   0.912 1.00 0.321 -0.993 0.325
Albumin (g/L) 38.57±3.56 36.92±4.73 37.60±4.77 1.845   0.069 -0.766 0.447 0.455 0.651
AST (U/L) 39.78±15.32 43.19±21.87 41.09±12.96 -0.822   0.413 0.217 0.787 -0.315 0.754
ALT (U/L) 37.87±19.31 33.41±19.64 33.53±10.85 1.043   0.300 -0.213 0.833 0.894 0.376
type of hepatectomy(Minor/Major) 29//22 33/19 7/5     0.496   0.927   0.743
Liver dysfunction 3 3 3     0.980   0.042   0.039
HBV reactivation 1 1 3     0.989   0.031   0.014